The Monitor Daily

Saturday, January 23, 2021
Log in

As a participant in the Amazon Services LLC Associates Program, this site may earn from qualifying purchases. We may also earn commissions on purchases from other retail websites.

  • Home
  • Politics & National News
  • Business News
  • Tech & Science
  • Health & Lifestyle
  • About us
    • Contact US
    • Privacy Policy GDPR
    • Terms of Use
  • Latest News
    • Stormy Planet
    • US Surgeon Performs Face Transplant
    • 2017 MTV VMAs Nominations Are In And Voting Is Now Open
    • Bright House: Free McAfee AntiVirus and Adult Controls
    • Antarctic Yeti Crab Gets Formal Scientific Name
    • Spiders Take Over Australian Town
    • Interesting Facts About the Apollo 11 Mission
    • Social Smoking or The New Landmark of Elegance Among Young Women
    • Rare Weasel Returns To Washington State

Pages

  • About The Monitor Daily
  • Contact US
  • Our Team
  • Privacy Policy GDPR
  • Terms of Use

Recent Posts

  • Precisely what is Administration Buyback? Feb 12, 2020
  • Precisely what is Administration Buyback? Feb 12, 2020
  • Where by do Registered requests get kept Dec 1, 2019
  • Find a Star of the event on the Submit Purchase New bride List May 19, 2019
  • Locate Really enjoy On the internet Apr 30, 2019
  • Get Love On the net Apr 12, 2019
  • NYC Man Snaps Photo of the Victim After Sucker-Punching Him in Broad Daylight Jun 29, 2018

Alzheimer Cure Targets Tau Protein

By Leave a Comment

brain doctor Alzheimer cure

Scientists try to find an Alzheimer cure by tampering with a tau protein.

Eli Lilly, a medical company that has been working for three decades in finding Alzheimer cure finally managed to get first results in its human testing program.

The latest drug works on an aberrant protein called tau. The protein spreads in the brain as Alzheimer progresses, accumulates in tangles and strangles brain cells and impairs them to function properly.

Until now, drug companies focused on amyloid, another protein that was thought to trigger the disease. Research clinics heavily invested in amyloid treatments, but with little to no success.

In 2010, Eli Lilly had to stop clinical trials because patients treated with the new drug were showing proofs of increased deterioration. In 2012, another company had to admit that their new medicine did not improve the condition.

In total, almost 190 Alzheimer drugs have failed to show any improvements in human trails.

The reason for which big pharma companies still try to obtain an Alzheimer cure is that there are more than 5 million Americans with the disease, and the number may double in the next thirty years.

The sale for existing medicine reached the value of $3 billion. And these drugs treat only the symptoms.

“If any of these drugs actually manage to slow the progress of the disease, their sales potential would be orders of magnitude higher,” says Sam Fazeli, senior pharmaceuticals analyst.

A century after the disease was discovered, scientists still do not know if the amyloid protein is the main cause of the condition or just a minor factor.

However, other companies such as Merck continue with the former theory and work on medicines based on a rare gene mutation that protects the brain against the amyloid spread. Merck will complete its final stage trial next year.

New approaches in curing Alzheimer have led to investments of $350 million. However, the tau protein had not so much time to be tested. Some companies even managed to obtain negative results when testing their drugs, as just a part of their trials showed improvements.

Other researchers believe that, while the amyloid is the trigger of the disease, the tau protein can be the factor that produces the brain tangles and clumps.

AbbVie and TauRX Pharmaceutics are other two companies that invest in new Alzheimer cures. The first results are expected to appear as early as July.

The vast majority of researchers say that the new drugs are more potent, and they prove to be more efficient when tested in the early stages of the conditions.

Image Source: YouTube

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Health & Lifestyle Tagged With: AbbVie, Alzheimer cure, Alzheimer Cure Targets Tau Protein, amyloid protein, clinical trials, Eli Lilly, human trials, tau protein, TauRX Pharmaceutics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 34 other subscribers

Operation Paperclip

Remembering Georg von Tiesenhausen, Last Member of Von Braun’s Rocket Team

By Leave a Comment

giant ground sloths on white background

It Seems that Giant Sloths Once Roamed Earth, and Humans Used to Hunt Them? (Study)

By Leave a Comment

sn 2001ig supernova explosion and images of its stars

A Star Escaped a Supernova Explosion, and NASA Snapped its Picture

By Leave a Comment

ngc 6420 galaxy resembling a giant butterfly

Hubble Spots Giant Butterfly Formed by a Black Hole and Stellar Winds (Study)

By Leave a Comment

infrared image of a dog

Space Technology Could Help Protect Earth’s Endangered Species

By Leave a Comment

snake slithering on a beige background

Kirigami Skin Is Helping a Soft Robot Slither Like a Snake (Study)

By Leave a Comment

woolly mammoth

Ice Age Tracks Reveal How Young Mammoths Cared for Adult Ones (Study)

By Leave a Comment

High Priestess tomb.

Archaeologists Discovered 4400-Years-Old High Priestess Tomb Near Cairo

By Leave a Comment

dwarf galaxies

Dwarf Galaxies Challenge the Entire Dark Matter Cosmology (Study)

By Leave a Comment

NASA Scientists and Food Experiments

NASA Scientists to Test if Astronauts Could Eat Their Own Poo

By Leave a Comment

KFC Smoky Wings Box Can Turn into Awesome Drone

By Leave a Comment

Tesla Model S

Tesla Model S Involved in Autopilot Malfunction Accident

By Leave a Comment

Duke Nukem.

John Cena Cold Feature in Duke Nukem Movie

By Leave a Comment

Battlefield One

Battlefield One Apocalypse DLC to Land in February

By Leave a Comment

Related Articles

  • eye procedure

    Queensland Mother Mutilated After Non-Invasive Eye Procedure Goes Sideways

  • HIV

    Northwest Arkansas Man Sentenced to 50 Years in Prison for Contracting HIV with the Purpose of Infecting Others

  • Meditation

    Yale Scientists Pinpointed the Brain Area for Spiritual Experiences

  • artificial intelligence

    Artificial Intelligence Outperforms Dermatologist in Melanoma Diagnosis

  • pill

    Arlington Doctor Gets 3 Years in Prison for Slipping Abortion Pill in Woman’s Tea

  • back of woman with short gray hair

    New Study Proposes Another Possible Cause for Gray Hair (Study)

  • two people jogging

    Being Physically Active Can Reportedly Make You Happier (Study)

  • OCD Twins Commit Suicide

    OCD Twins Committed Suicide, Freemont County Sheriff Confirms

  • fingerprint

    You Might Have Traces of Class A Drugs on Your Fingerprints

  • Bariatric surgery

    Star of ‘My 600-Lbs Life’ Dies of Heart Attack Following Bariatric Surgery

Categories

  • Business News
  • Entertainment
  • Featured
  • Health & Lifestyle
  • Nature
  • Politics & National
  • Sports
  • Tech & Science
  • US
  • World

Copyright © 2021 TheMonitorDaily.com

About · Privacy Policy · Terms of Use · Sitemap · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.